These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Cerebral-activating (EEG) properties of two inverse agonists and of an antagonist at the benzodiazepine receptor in the rat. Santucci V; Fournier M; Worms P; Keane P; Bizière K Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):93-100. PubMed ID: 2571947 [TBL] [Abstract][Full Text] [Related]
44. Does dihydrohonokiol, a potent anxiolytic compound, result in the development of benzodiazepine-like side effects? Kuribara H; Kishi E; Maruyama Y J Pharm Pharmacol; 2000 Aug; 52(8):1017-22. PubMed ID: 11007074 [TBL] [Abstract][Full Text] [Related]
45. The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam. Costall B; Jones BJ; Kelly ME; Naylor RJ; Oakley NR; Onaivi ES; Tyers MB Pharmacol Biochem Behav; 1989 Dec; 34(4):769-78. PubMed ID: 2576143 [TBL] [Abstract][Full Text] [Related]
46. Effects of diazepam and zolpidem on EEG beta frequencies are behavior-specific in rats. van Lier H; Drinkenburg WH; van Eeten YJ; Coenen AM Neuropharmacology; 2004 Aug; 47(2):163-74. PubMed ID: 15223295 [TBL] [Abstract][Full Text] [Related]
47. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone. Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317 [TBL] [Abstract][Full Text] [Related]
48. Lack of effect of flumazenil and CGS 8216 on the anxiolytic-like properties of loreclezole. Dawson GR; Curnow R; Bayley P; Rambridge A; Tricklebank MD Eur J Pharmacol; 1994 Feb; 252(3):325-8. PubMed ID: 7909294 [TBL] [Abstract][Full Text] [Related]
49. Kaempferol from the leaves of Apocynum venetum possesses anxiolytic activities in the elevated plus maze test in mice. Grundmann O; Nakajima J; Kamata K; Seo S; Butterweck V Phytomedicine; 2009 Apr; 16(4):295-302. PubMed ID: 19303276 [TBL] [Abstract][Full Text] [Related]
50. A possible mechanism for anxiolytic and antidepressant effects of alpha- and beta-amyrin from Protium heptaphyllum (Aubl.) March. Aragão GF; Carneiro LM; Junior AP; Vieira LC; Bandeira PN; Lemos TL; Viana GS Pharmacol Biochem Behav; 2006 Dec; 85(4):827-34. PubMed ID: 17207523 [TBL] [Abstract][Full Text] [Related]
51. Pharmacological characterization of 6-bromo-3'-nitroflavone, a synthetic flavonoid with high affinity for the benzodiazepine receptors. Wolfman C; Viola H; Marder M; Ardenghi P; Wasowski C; Schröder N; Izquierdo I; Rúveda E; Paladini A; Medina JH Pharmacol Biochem Behav; 1998 Nov; 61(3):239-46. PubMed ID: 9768558 [TBL] [Abstract][Full Text] [Related]
52. Melatonin as an anxiolytic in rats: time dependence and interaction with the central GABAergic system. Golombek DA; Martini M; Cardinali DP Eur J Pharmacol; 1993 Jun; 237(2-3):231-6. PubMed ID: 8103462 [TBL] [Abstract][Full Text] [Related]
53. Anxiolytic-like effects of PNU-101017, a partial agonist at the benzodiazepine receptor. Tang AH; Franklin SR; Carter DB; Sethy VH; Needham LM; Jacobsen EJ; Von Voigtlander PF Psychopharmacology (Berl); 1997 Jun; 131(3):255-63. PubMed ID: 9203236 [TBL] [Abstract][Full Text] [Related]
55. Differential profile of the CCKB receptor antagonist CI-988 and diazepam in the four-plate test. Dooley DJ; Klamt I Psychopharmacology (Berl); 1993; 112(4):452-4. PubMed ID: 7871056 [TBL] [Abstract][Full Text] [Related]
56. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs? Consoli D; Leggio GM; Mazzola C; Micale V; Drago F Eur J Pharmacol; 2007 Nov; 573(1-3):139-47. PubMed ID: 17669397 [TBL] [Abstract][Full Text] [Related]
57. Effects of benzodiazepine and GABA antagonists on anticonflict effects of antianxiety drugs injected into the rat amygdala in a water-lick suppression test. Shibata S; Yamashita K; Yamamoto E; Ozaki T; Ueki S Psychopharmacology (Berl); 1989; 98(1):38-44. PubMed ID: 2567034 [TBL] [Abstract][Full Text] [Related]
58. 3-((+-)-2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) and phencyclidine produce a deficit of passive avoidance retention in rats. DeNoble VJ; Jones KW; Schaeffer CL; Bauerle LM Eur J Pharmacol; 1990 Jan; 175(2):197-202. PubMed ID: 2107089 [TBL] [Abstract][Full Text] [Related]
59. Effect of a new anxiolytic, DN-2327, on learning and memory in rats. Wada T; Fukuda N Pharmacol Biochem Behav; 1992 Mar; 41(3):573-9. PubMed ID: 1350101 [TBL] [Abstract][Full Text] [Related]